Zhuohui Luo
Hainan Pharmaceutical Research And Development Science Park
Haikou, China
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cajanolactone A alleviates high-fat diet-induced MAFLD by modulating liver de novo lipogenesis, inflammatory signaling, and bile acid composition in the gut-liver axis.
Journal: Biochemical pharmacology
Published: November 06, 2025
3'-hydroxypuerarin mitigates LPS-induced acute lung injury by inhibiting TLR4 activation-mediated NF-κB p65/NLRP3/GSDMD signaling.
Journal: Frontiers in immunology
Published: September 09, 2025
Citri Sarcodactylis Fructus Alleviates LPS-Induced Acute Lung Injury by Inhibiting Inflammation and Inflammasome Activation.
Journal: Food science & nutrition
Published: June 12, 2025
Ginsenoside Rg2 ameliorates metabolic dysfunction-related steatohepatitis via the Nrf2 pathway by suppressing inflammation, apoptosis, oxidative stress and fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 22, 2025
Sinensetin attenuates LPS-induced acute pulmonary inflammation in mice and RAW264.7 cells by modulating NF-κB p65-mediated immune resistance and STAT3-mediated tissue resilience.
Journal: International immunopharmacology
Published: November 06, 2024
Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways.
Journal: Frontiers in pharmacology
Published: September 14, 2024
Exocarpium Citri Grandis ameliorates LPS-induced acute lung injury by suppressing inflammation, NLRP3 inflammasome, and ferroptosis.
Journal: Journal of ethnopharmacology
Published: January 14, 2024
An Integrated Pharmacology-Based Strategy to Investigate the Potential Mechanism of Xiebai San in Treating Pediatric Pneumonia.
Journal: Frontiers in pharmacology
Published: September 28, 2021
Last Updated: 09/26/2026